Latest Stories
FTC Wins Nod to Move Ahead With Surescripts Monopolization Case
The Federal Trade Commission won approval to move forward with a case alleging information technology firm Surescripts LLC conspired to maintain monopolies over electronic prescribing markets.
Medicare Advantage Plans Await Contentious 2024 Rate Details
Intense lobbying will give way to action once the Biden administration announces whether it will delay, alter, or finalize its polarizing proposal to change the way Medicare managed care plans are paid.
US Silver Sued Over Discharge of Arsenic, Lead Into Idaho River
A silver mining company in Idaho illegally discharged arsenic, lead, and other pollutants into the South Fork Coeur d’Alene River, an environmental group alleged in a federal lawsuit.
Tyson Foods to Face Covid Vaccine Objector’s Unpaid Leave Claim
A Christian former
Social Security Finance Outlook Dims While Medicare’s Improves
The Social Security system’s retiree fund will be able to fully pay scheduled benefits until 2033, one year earlier than reported last year.
Featured Topics
drug pricing
Mylan Beats Securities Class Action Over EpiPen, Generic Drugs
How Community Health Centers and PhRMA Went From Foes to Friends
Teva-GSK Drug Labeling Fight Needs High Court Review, DOJ Says
medical research
Tyson Foods to Face Covid Vaccine Objector’s Unpaid Leave Claim
FDA Can Apply Faster Drug Withdrawal Powers Without New Guidance
Sartorius to Buy French Biotech Polyplus for $2.6 Billion (1)
pharmaceuticals
Mylan Beats Securities Class Action Over EpiPen, Generic Drugs
FTC Wins Nod to Move Ahead With Surescripts Monopolization Case
Medicare Advantage Plans Await Contentious 2024 Rate Details
Other Topics
Covid-19 Vaccine: Can Your Employer Make You Take It?
Up Next
